Link between serum sclerostin and osteoprotegerin in the prognosis of ACM

A research looked at the relationship between serum sclerostin and osteoprotegerin (OPG) and Acute Myocardial Infarction (ACM) patients' prognosis and severity. The AMI group (n=92) had greater blood levels of sclerostin and OPG than the non-AMI group (n=60) in this research. OPG that has been Ln-transformed has been connected to MACE. Bone-related proteins may help with early risk stratification and prognosis evaluation in patients with AMI.